These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 5125064
21. Effects of amantadine on tardive dyskinesia and pseudo-parkinsonism. Janowsky DS, el-Yousef MK, Davis JM, Sekerke HJ, Morris DR, Decker B. N Engl J Med; 1972 Apr 06; 286(14):785. PubMed ID: 4554521 [No Abstract] [Full Text] [Related]
22. [Therapy of extrapyramidal-motor symptoms. Drug treatment]. Hartmann-von Monakow K. Bibl Psychiatr Neurol; 1969 Apr 06; 139():697-704. PubMed ID: 5406928 [No Abstract] [Full Text] [Related]
23. Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations. Furukawa Y, Filiano JJ, Kish SJ. Mov Disord; 2004 Oct 06; 19(10):1256-8. PubMed ID: 15389992 [Abstract] [Full Text] [Related]
24. Drugs and motor functions. Gordon N. Dev Med Child Neurol; 1971 Jun 06; 13(3):384-6. PubMed ID: 4398415 [No Abstract] [Full Text] [Related]
25. [Therapeutic use of tiapride in movement disorders]. Mathé JF, Cler JM, Venisse JL. Sem Hop; 1978 May 06; 54(13-16):517-20. PubMed ID: 211595 [Abstract] [Full Text] [Related]
26. Movement disorders in the elderly. Gilmore R. Geriatrics; 1984 Jun 06; 39(6):65-8, 72-6. PubMed ID: 6144615 [No Abstract] [Full Text] [Related]
27. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs]. Ferrari P, Robotti E, Nardini M. Boll Chim Farm; 1972 Oct 06; 111(10):610-5. PubMed ID: 4566407 [No Abstract] [Full Text] [Related]
28. [L-dopa-induced movement disorders in Parkinson disease. Amantadine improves dyskinesia]. MMW Fortschr Med; 2001 May 28; 143 Suppl 2():93. PubMed ID: 11434272 [No Abstract] [Full Text] [Related]
30. An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesias. Mark MH, Sage JI. Ann Clin Lab Sci; 1994 May 28; 24(1):12-21. PubMed ID: 8147565 [Abstract] [Full Text] [Related]
37. [Experimental and clinical data on the mechanism of action of amantadine and on its effectiveness in Parkinson's disease]. Beani L, Bianchi C, Gomirato G, Perfetti C, Cartei M. Minerva Med; 1971 Oct 31; 62(82):3948-51. PubMed ID: 5125048 [No Abstract] [Full Text] [Related]
38. [Therapeutic findings in hemiballism and hemichorea]. Kato T, Yoshioka T, Tauchi K. Saishin Igaku; 1969 Nov 31; 24(11):2312-7. PubMed ID: 5359817 [No Abstract] [Full Text] [Related]
39. Amantadine hydrochloride treatment of tardive dyskinesia. Decker BL, Davis JM, Jonowsky DS, el-Yousef MK, Sekerke HJ. N Engl J Med; 1971 Oct 07; 285(15):860. PubMed ID: 5570853 [No Abstract] [Full Text] [Related]
40. [Conservative therapy in the Parkinson syndrome]. Birkmayer W. Wien Med Wochenschr; 1971 Nov 13; 121(46):827-9. PubMed ID: 5138823 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]